Reviewchondromodulin (cas 136362-10-2)-I and tenomodulin: A new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues

Add time:09/07/2019    Source:sciencedirect.com

In tissues and/or organs of mesenchymal origin, the vasculature is usually well developed. However, there are certain hypovascular tissues that exhibit powerful anti-angiogenic resistance, implying the presence of tissue-type specific inhibitors of angiogenesis. Hyaline cartilage is one example, and several anti-angiogenic factors have been purified from cartilage. We previously identified chondromodulin-I (ChM-I) as a tissue-specific inhibitor of angiogenesis in fetal bovine cartilage. ChM-I is specifically expressed in the avascular regions of the growth-plate and cartilaginous bone rudiments in embryos. Recently, we cloned a novel type II transmembrane protein, tenomodulin (TeM), having a domain homologous to ChM-I at its C-terminus. TeM turned out to be expressed specifically in other hypovascular structures in the mesenchyme, such as the epimysium, tendon, and ligaments. In this overview, we discuss the structural characteristics of this class of anti-angiogenic molecules and their pathophysiological role in the control of vascularity.

We also recommend Trading Suppliers and Manufacturers of chondromodulin (cas 136362-10-2). Pls Click Website Link as below: cas 136362-10-2 suppliers

Prev:chondromodulin (cas 136362-10-2) I and pleiotrophin gene expression in bovine cartilage and epiphysis
Next:Differential expression of Tenomodulin and chondromodulin (cas 136362-10-2)-1 at the insertion site of the tendon reflects a phenotypic transition of the resident cells)